Simone Claudiani

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Tyrosine Kinase

Systemic Lupus Erythematosus

Chronic Myeloid Leukemia

Ejection Fraction

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Simone Claudiani, Lynette Chee, Fiona Fernando, Loretta Brown, Udayakumar M Achandira, Afzal Khan, Kate Rothwell, Chloe Hayden, Ioannis Koutsavlis, Guy Hannah, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations. American journal of hematology (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Lynette Chee, Fiona Fernando, Loretta Brown, Udayakumar M Achandira, Afzal Khan, Kate Rothwell, Chloe Hayden, Ioannis Koutsavlis, Guy Hannah, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations. American journal of hematology (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Lynette Chee, Fiona Fernando, Loretta Brown, Udayakumar M Achandira, Afzal Khan, Kate Rothwell, Chloe Hayden, Ioannis Koutsavlis, Guy Hannah, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations. American journal of hematology 99 (6) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia (2024)
Simone Claudiani, Lynette Chee, Fiona Fernando, Loretta Brown, Udayakumar M Achandira, Afzal Khan, Kate Rothwell, Chloe Hayden, Ioannis Koutsavlis, Guy Hannah, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations. American journal of hematology 99 (6) (2024)
Simone Claudiani, Jane F Apperley, Eleanor L Parker, Federica Marchesin, Ksenia Katsanovskaja, Renuka Palanicawandar, Andrew J Innes, Richard S Tedder, Myra O McClure, Dragana Milojkovic
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors. British journal of haematology 197 (1) (2021)
Simone Claudiani
Is COVID-19 less severe in CML patients than in those with other haematological cancers? British journal of haematology (2021)
Simone Claudiani, Jane F Apperley, Richard Szydlo, Afzal Khan, George Nesr, Chloe Hayden, Andrew J Innes, Kathy Dominy, Pierre Foskett, Letizia Foroni, Jamshid S Khorashad, Dragana Milojkovic
TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia. British journal of haematology 193 (2) (2020)